ProductsDistribution Products


Therapeutic indication:

Ixiaro is indicated for active immunization against Japanese encephalitis in adults, adolescents, children and infants aged 2 months and older. Ixiaro should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.

  • Composition: Japanese encephalitis purified inactivated vaccine 6au / 0.5 ml
  • Pharmaceutical form: Suspension for injection
  • Method of administration: Intramuscular
  • Manufacturer: Valneva